These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34515070)

  • 1. Endotoxin and Cytokine Sequential Hemoadsorption in Septic Shock and Multi-Organ Failure.
    Ruiz-Rodríguez JC; Chiscano-Camón L; Palmada C; Ruiz-Sanmartin A; Pérez-Carrasco M; Larrosa N; González JJ; Hernández-González M; Ferrer R
    Blood Purif; 2022; 51(7):630-633. PubMed ID: 34515070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential Extracorporeal Therapy Collaborative Device and Timely Support for Endotoxic, Septic, and Cardiac Shock: A Case Report.
    De Rosa S; Samoni S; Ronco C
    Blood Purif; 2020; 49(4):502-508. PubMed ID: 31865323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.
    Mitaka C; Tsuchida N; Kawada K; Nakajima Y; Imai T; Sasaki S
    Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
    Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
    Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin B hemoperfusion: a mechanistic perspective.
    Ronco C; Klein DJ
    Crit Care; 2014 Jun; 18(3):309. PubMed ID: 25043934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
    Dellinger RP; Bagshaw SM; Antonelli M; Foster DM; Klein DJ; Marshall JC; Palevsky PM; Weisberg LS; Schorr CA; Trzeciak S; Walker PM;
    JAMA; 2018 Oct; 320(14):1455-1463. PubMed ID: 30304428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application.
    Shoji H; Tani T; Hanasawa K; Kodama M
    Ther Apher; 1998 Feb; 2(1):3-12. PubMed ID: 10227782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure.
    Ikeda T; Ikeda K; Nagura M; Taniuchi H; Matsushita M; Kiuchi S; Kuroki Y; Suzuki K; Matsuno N
    Ther Apher Dial; 2004 Aug; 8(4):293-8. PubMed ID: 15274680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
    Nakamura T; Sugaya T; Koide H
    Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
    J Crit Care; 2011 Dec; 26(6):546-9. PubMed ID: 21273029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
    Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
    G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal removal of endotoxin: the polymyxin B-immobilized fiber cartridge.
    Tani T; Shoji H; Guadagni G; Perego A
    Contrib Nephrol; 2010; 167():35-44. PubMed ID: 20519897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.
    Aoki H; Kodama M; Tani T; Hanasawa K
    Am J Surg; 1994 Apr; 167(4):412-7. PubMed ID: 8179086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
    Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
    Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
    Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
    Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber.
    Nakamura T; Ebihara I; Shimada N; Koide H
    Intensive Care Med; 1998 Dec; 24(12):1272-6. PubMed ID: 9885879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.
    Payen DM; Guilhot J; Launey Y; Lukaszewicz AC; Kaaki M; Veber B; Pottecher J; Joannes-Boyau O; Martin-Lefevre L; Jabaudon M; Mimoz O; Coudroy R; Ferrandière M; Kipnis E; Vela C; Chevallier S; Mallat J; Robert R;
    Intensive Care Med; 2015 Jun; 41(6):975-84. PubMed ID: 25862039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.
    Mitaka C; Fujiwara N; Yamamoto M; Toyofuku T; Haraguchi G; Tomita M
    J Crit Care; 2014 Oct; 29(5):728-32. PubMed ID: 24798345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.